OECD TG 423
OECD TG 423 is the standard ‘Acute Oral Toxicity – Acute Toxicity Class Method’, i.e. Acute Oral Toxicity – Acute Toxicity Class Method, which is listed under Section 4 (Health Effects) of the OECD Test Guidelines for the Testing of Chemicals. It was first adopted in 1996 and updated in 2001. The test is an in vivo toxicity test designed to assess the acute toxic effects of a substance following a single oral administration.
The main objective of OECD TG 423 is to determine the acute oral toxicity potential of the substance and its GHS/CLP classification, using fewer animals and prioritising animal welfare compared with the traditional LD50 determination approach. The method uses fixed doses and a staircase design; rather than determining an exact LD50 value, it aims to establish the toxicity class to which the substance belongs.
The basic principle of the test is as follows:
- The test substance is administered orally to the animals at specific fixed doses (usually 5, 50, 300 and 2000 mg/kg body weight).
- Three animals (usually female rats) are generally used per dose level; depending on the results, further animals may be added or the study may proceed to the next dose level.
- The substance is usually administered to rats as a single dose in a suitable vehicle.
- The animals are kept under clinical observation for at least 14 days; during this period, signs of toxicity, reversibility, changes in body weight and mortality are recorded.
- At the end of the study, a post-mortem examination is carried out and the macroscopic findings are documented.
- Thanks to the stepwise trial design, it is not necessary to test all dose levels; depending on the mortality observed, the trial moves on to the next higher or next lower dose level.
The key features of the process are:
- Fixed dose levels: 5, 50, 300 and 2000 mg/kg
- Staircase design: switching between dose levels depending on the mortality response
- Starting dose: Selected on the basis of available data and structural similarities; 300 mg/kg is generally preferred as the starting value
- Reduction in the number of animals: Significantly fewer animals are used compared with conventional LD50 tests
- GHS/CLP classification: The mortality data obtained are used to determine the categories of acute oral toxicity
The main parameters reported in the study are as follows:
- The dose levels administered (mg/kg) and the number of animals per dose level
- Clinical observations and their onset
- Changes in body weight
- Mortality and survival times
- Post-mortem findings
- GHS/CLP category for acute oral toxicity and justification for the classification
- Estimated LD50 range (no exact value)
- Animal species used, sex, age, method of administration and conditions of use
- Data on measurement uncertainty and repeatability
Why is it carried out?
OECD TG 423 is being carried out for the following scientific and regulatory purposes:
- Assessment of acute oral toxicity: identification of toxic effects and target organs following a single oral exposure
- GHS/CLP classification: Determination of the substance’s acute oral toxicity category and specification of labelling requirements
- Prioritisation of animal welfare (3Rs): reduction in the number of animals used compared with conventional LD50 tests and minimisation of severe pain and suffering
- Support with regulatory documentation: Use in safety assessments of chemicals, pesticides, biocidal products, medicinal products and medical devices
- Contribution to risk assessment: Provision of baseline data for risk assessment in acute exposure scenarios
- Prioritisation: Reviewing a large number of substances and setting priorities for further testing
- Labelling and transport: Data on acute oral toxicity are used in the classification of chemicals for the purposes of labelling and transport
- Evidence-based approach: A contribution to the holistic assessment of the substance in conjunction with other toxicological, physicochemical and exposure data
OECD TG 423 zielt nicht darauf ab, einen eindeutigen LD50-Wert zu ermitteln; stattdessen liefert sie eine Einstufung auf der Grundlage stufenweiser Mortalitätsdaten. Die Ergebnisse sollten im Zusammenhang mit der chemischen Struktur der Substanz, anderen Daten zur akuten Toxizität (z. B. TG 420, TG 425), der Toxizität bei wiederholter Verabreichung sowie der Expositionsbewertung interpretiert werden.
As part of our nano-testing services, we carry out acute oral toxicity studies in accordance with OECD TG 423, applying scientific rigour and utilising our accredited laboratory facilities and quality management system. Our scope of services includes the following:
Study design and protocol development
Preparation of a test report in accordance with OECD TG 423
Scientific justification for the starting dose and the stepwise dosing regimen, based on the physicochemical properties of the test substance and the available toxicity data
Selection of a suitable vehicle and assessment of solubility and stability; determination of animal species, sex, age and administration conditions; compliance with ethical approval and animal welfare requirements; planning of a stepwise experimental design to minimise the number of animals
Please feel free to contact Nano-Test for information on study design, selection of the starting dose, suitability of the vehicle, sample collection conditions, the timetable and reporting procedures for your acute oral toxicity studies in accordance with OECD TG 423.

